Wilbanks G - Search Results

1

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R. Pal T, et al. Among authors: wilbanks g. Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991 Free article.

2

Cytology of human ovarian surface epithelial brushings.

Nicosia SV, Wilbanks GD, Saunders B, Mayer J, Cardosi RJ, Kruk PA, Cheng J, Bai W, Coppola D, Fiorica J. Nicosia SV, et al. Cancer. 2004 Feb 25;102(1):1-10. doi: 10.1002/cncr.20001. Cancer. 2004. PMID: 14968412 Free article.

3

Lysophospholipids are potential biomarkers of ovarian cancer.

Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K, Griffin D, Blanco RW, Cantor AB, Xiao YJ, Krischer JP. Sutphen R, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1185-91. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247129

4

Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.

Drenberg CD, Saunders BO, Wilbanks GD, Chen R, Nicosia RF, Kruk PA, Nicosia SV. Drenberg CD, et al. Among authors: wilbanks gd. Gynecol Oncol. 2010 Apr;117(1):117-24. doi: 10.1016/j.ygyno.2009.12.011. Epub 2010 Jan 13. Gynecol Oncol. 2010. PMID: 20071014

5

Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer.

Szlosarek PW, Grimshaw MJ, Wilbanks GD, Hagemann T, Wilson JL, Burke F, Stamp G, Balkwill FR. Szlosarek PW, et al. Among authors: wilbanks gd. Int J Cancer. 2007 Jul 1;121(1):6-11. doi: 10.1002/ijc.22666. Int J Cancer. 2007. PMID: 17354225 Free article.

6

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR. Scotton CJ, et al. Among authors: wilbanks gd. Cancer Res. 2002 Oct 15;62(20):5930-8. Cancer Res. 2002. PMID: 12384559

7

Oral contraceptives and endometrial cancer: do other risk factors modify the association?

Stanford JL, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Hoover RN. Stanford JL, et al. Among authors: wilbanks gd. Int J Cancer. 1993 May 8;54(2):243-8. doi: 10.1002/ijc.2910540214. Int J Cancer. 1993. PMID: 8486426

8

Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.

Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA. Sturgeon SR, et al. Among authors: wilbanks gd. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):231-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521439

9

Past and present physical activity and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD. Sturgeon SR, et al. Among authors: wilbanks gd. Br J Cancer. 1993 Sep;68(3):584-9. doi: 10.1038/bjc.1993.390. Br J Cancer. 1993. PMID: 8353048 Free PMC article.

10

Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.

Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F, Balkwill FR. Szlosarek PW, et al. Mol Cancer Ther. 2006 Feb;5(2):382-90. doi: 10.1158/1535-7163.MCT-05-0303. Mol Cancer Ther. 2006. PMID: 16505113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page